Skip to content

Comparing effect of oral omeprazole versus intravenous pantaprazole in peptic ulcer bleeding

Comparing effect of oral omeprazole versus intravenous pantaprazole in peptic ulcer bleeding

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138711191650N1
Enrollment
80
Registered
2010-01-03
Start date
2008-11-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peptic ulcer, bleeding. Peptic ulcer, site unspecified

Interventions

Intervention 1: All patients who admit in odd days will take oral omeprazole (40 mg po BID ) and then 20 mg omeprazole daily up to 14 days.All patient will evaluate endoscopically and endoscopic in
Treatment - Drugs
All patients who admit in odd days will take oral omeprazole (40 mg po BID ) and then 20 mg omeprazole daily up to 14 days.All patient will evaluate endoscopically and endoscopic intervention would
patients who will admit in even days will recieve pantoprazole ( 8 mg / hour ) for 72 or 48 hour and then take omeprazole 20 mg daily up to 14 days .

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA ;All patient who admite in hospital due to GI bleeding and have high risk ulcer in endoscopic evaluation. EXCLUSION CRITERIA ;Any patient who find to have esophageal varices ,bleeding tendency ,GI cancer ,uremia or Mallory Weiss tear.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Recurrent bleeding. Timepoint: daily up to discharge and after 14 days. Method of measurement: hypotension,tachucardia ,Hb drop ,hematemesis after stabilization and recurrence of melena after normal stool.;Surgery. Timepoint: daily up to discharge and after 14 days. Method of measurement: daily up to discharge and phone call after 2 weeks.;Mortality (All cause ). Timepoint: daily up to discharge. Method of measurement: daily up to discharge and phone call after 2 weeks.

Secondary

MeasureTime frame
Blood transfusion. Timepoint: during discharge. Method of measurement: number of transfused blood packed cells.;Hospital stay. Timepoint: daily. Method of measurement: assess during discharge.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Alireza Hashemi

Shiraz University of Medical Sciences

hashemiar@sums.ac.ir hashemiar116@yahoo.com+98 71 1832 3317

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026